Associated Papers
Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.
Ng J et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2024
38180245 (PubMed )
Supplement: ccr-23-2360_supplementary_table_s4_suppst4.xlsx › S.Table_4
Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines.
Medina PP et al.
Human Mutation, 2008
Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
Medina PP et al.
Epigenetics, 0
Select a paper to view details